Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yue Hu, Xiaojiao Li, Jingrui Liu, Hong Chen, Wenbo Zheng, Hong Zhang, Min Wu, Cuiyun Li, Xiaoxue Zhu, Jinfeng Lou, Pangke Yan, Nan Wu, Xiao Liu, Shiping Ma, Xu Wang, Yanhua Ding & Chengluan Xuan. (2022) Safety, pharmacokinetics and pharmacodynamics of a novel γ-aminobutyric acid (GABA) receptor potentiator, HSK3486, in Chinese patients with hepatic impairment. Annals of Medicine 54:1, pages 2757-2768.
Read now
Read now
Mohd Yaseen Malik, Swati Jaiswal, Abhisheak Sharma, Mahendra Shukla & Jawahar Lal. (2016) Role of enterohepatic recirculation in drug disposition: cooperation and complications. Drug Metabolism Reviews 48:2, pages 281-327.
Read now
Read now
Articles from other publishers (14)
Jorge L. Poo, Juan R. Aguilar, Raul Bernal-Reyes, Rosalba Alonso-Campero, Frida Gasca, Larissa Hernández, Everardo Pineyro-Garza, Magdalena Gomez-Silva, Maria Elena Gamino, Mario González-de la Parra, Pedro Peña, Nadiel Hernández, Graciela Tapia & Linda E. Muñoz-Espinosa. (2023) Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study. Biomedicine & Pharmacotherapy 168, pages 115712.
Crossref
Crossref
Helena Colom, Annabel Blasi, Bruno Montoro, Angel‐Guillermo Arévalo, Josep Maria Cendrós & Antoni Sabaté. (2023) Population pharmacokinetic modelling of fibrinogen in patients with congenital or acquired—chronic or acute—hypofibrinogenaemia. British Journal of Clinical Pharmacology 89:9, pages 2703-2713.
Crossref
Crossref
Ronaldo Morales Junior, João Paulo Telles, Shaina Ying‐Ching Kwiatkowski, Vanessa D'Amaro Juodinis, Daniela Carla de Souza & Silvia Regina Cavani Jorge Santos. (2023) Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients. Liver Transplantation 29:1, pages 91-102.
Crossref
Crossref
Lorenzo Onorato, Caterina Monari, Salvatore Capuano, Pierantonio Grimaldi & Nicola Coppola. (2022) Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative Review. Antibiotics 11:2, pages 232.
Crossref
Crossref
Qin Ning, Tao Chen, Guiqiang Wang, Dong Xu, Yanyan Yu, Qing Mao, Taisheng Li, Lanjuan Li, Jun Li, Xiaoju Lu, Jiabin Li, Zhiwei Li, Wenhong Zhang, Yonghong Xiao, Qinghua Meng, Yuqiang Mi, Jia Shang, Yunsong Yu, Yingren Zhao, Caiyan Zhao, Hong Zhao, Jianrong Huang, Jie Peng, Hong Tang, Xiaoping Tang, Jinhua Hu, Bijie Hu, Wei Guo, Bo Zheng, Baiyi Chen, Yuexin Zhang, Jia Wei, Jifang Sheng, Zhi Chen, Minggui Wang, Qing Xie, Yuming Wang, Fu-Sheng Wang, Jinlin Hou, Zhongping Duan, Lai Wei & Jidong Jia. (2022) Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infections. Infectious Diseases & Immunity 2:3, pages 168-178.
Crossref
Crossref
Eman El‐Khateeb, Adam S. Darwich, Brahim Achour, Varinder Athwal & Amin Rostami‐Hodjegan. (2021) Review article: time to revisit Child‐Pugh score as the basis for predicting drug clearance in hepatic impairment. Alimentary Pharmacology & Therapeutics 54:4, pages 388-401.
Crossref
Crossref
Giovanni Galati, Antonio Fabio Massimo Vainieri, Claudia Angela Maria Fulgenzi, Stefano Di Donato, Marianna Silletta, Paolo Gallo, Angelo Onorato, Umberto Vespasiani-Gentilucci & Antonio Picardi. (2020) Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis. Current Drug Metabolism 21:11, pages 866-884.
Crossref
Crossref
Taotao Wang, Miao Yan, Dan Tang, Yuzhu Dong, Li Zhu, Qian Du, Dan Sun, Jianfeng Xing & Yalin Dong. (2020) Using Child‐Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model‐based Analysis. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
Crossref
Crossref
Soma Banerjee & Marit Nilsen-Hamilton. 2020. E. Coli Infections - Importance of Early Diagnosis and Efficient Treatment. E. Coli Infections - Importance of Early Diagnosis and Efficient Treatment.
Nikolaos Spernovasilis & Diamantis Kofteridis. (2018) Pre-Existing Liver Disease and Toxicity of Antifungals. Journal of Fungi 4:4, pages 133.
Crossref
Crossref
T. Wang, M. Yan, D. Tang, L. Xue, T. Zhang, Y. Dong, L. Zhu, X. Wang & Y. Dong. (2018) A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child-Pugh class C cirrhosis. Journal of Clinical Pharmacy and Therapeutics 43:6, pages 849-854.
Crossref
Crossref
Taotao Wang, Miao Yan, Dan Tang, Ling Xue, Tao Zhang, Yuzhu Dong, Li Zhu, Xinggang Wang & Yalin Dong. (2018) Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child–Pugh class B and C cirrhosis: A multicenter study. International Journal of Infectious Diseases 72, pages 49-54.
Crossref
Crossref
Jesus Ruiz, Paula Ramirez, María José Company, Mónica Gordon, Esther Villarreal, Pablo Concha, María Aroca, Juan Frasquet, María Remedios-Marqués & Álvaro Castellanos-Ortega. (2018) Impact of amikacin pharmacokinetic/pharmacodynamic index on treatment response in critically ill patients. Journal of Global Antimicrobial Resistance 12, pages 90-95.
Crossref
Crossref
Jessica E. Bollinger. 2017. Surgical Procedures on the Cirrhotic Patient. Surgical Procedures on the Cirrhotic Patient
29
39
.